小児仙痛:世界の治験レビュー(2017年下半期版)

【英語タイトル】Infantile colic Global Clinical Trials Review, H2, 2017

GlobalDataが出版した調査資料(GDHC4653CTIDB)・商品コード:GDHC4653CTIDB
・発行会社(調査会社):GlobalData
・発行日:2017年10月31日
・ページ数:53
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD5,000 ⇒換算¥545,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD7,500 ⇒換算¥817,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界における小児仙痛治療の臨床試験動向について調査・分析し、アジア/ヨーロッパ/アメリカ/中南米の主要国における治験件数、フェーズ別の治験件数、進捗状況別の治験件数、有望なスポンサー、有望な薬剤、治験関連の最新ニュース、主要企業分析、主要な治験プロファイル分析などの情報をご提供致します。
・小児仙痛:主要地域別治験動向
・小児仙痛:アジア市場
・小児仙痛:ヨーロッパ市場
・小児仙痛:アメリカ市場
・小児仙痛:中南米市場
・小児仙痛:中東・アフリカ市場
・小児仙痛:段階(フェーズ)別治験件数
・小児仙痛:進捗状況別の治験件数
・小児仙痛:スポンサーの種類別治験件数
・小児仙痛:有望なスポンサー
・小児仙痛:有望な薬剤分析
・小児仙痛:主要企業分析
【レポートの概要】

Infantile colic Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Infantile colic Global Clinical Trials Review, H2, 2017″ provides an overview of Infantile colic clinical trials scenario. This report provides top line data relating to the clinical trials on Infantile colic. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Infantile colic to Other Diseases Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Infantile colic to Other Diseases Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Infantile colic Therapeutics Clinical Trials 27
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
Appendix 51
Abbreviations 51
Definitions 51
Research Methodology 52
Secondary Research 52
About GlobalData 53
Contact Us 53
Source 53

List of Tables
Infantile colic Therapeutics, Global, Clinical Trials by Region, 2017* 6
Infantile colic Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Infantile colic Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Infantile colic Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 9
Infantile colic Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
Infantile colic Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
Infantile colic Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
Infantile colic Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
Proportion of Infantile colic to Other Diseases Clinical Trials, G7 Countries (%), 2017* 14
Infantile colic Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Infantile colic Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Infantile colic to Other Diseases Clinical Trials, E7 Countries (%), 2017* 17
Infantile colic Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Infantile colic Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
Infantile colic Therapeutics, Global, Clinical Trials by Phase, 2017* 20
Infantile colic Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
Infantile colic Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
Infantile colic Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
Infantile colic Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
Infantile colic Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
Infantile colic Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
Infantile colic Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Infantile colic Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List of Figures
Infantile colic Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Infantile colic Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Infantile colic Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Infantile colic Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 9
Infantile colic Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
Infantile colic Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
Proportion of Infantile colic to Other Diseases Clinical Trials, G7 Countries (%), 2017* 14
Infantile colic Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Infantile colic Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Infantile colic to Other Diseases Clinical Trials, E7 Countries (%), 2017* 17
Infantile colic Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Infantile colic Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
Infantile colic Therapeutics, Global, Clinical Trials by Phase (%), 2017* 20
Infantile colic Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 21
Infantile colic Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
Infantile colic Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
Infantile colic Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
Infantile colic Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 25
Infantile colic Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
Infantile colic Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
Infantile colic Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
GlobalData Methodology 52

【掲載企業】

BioGaia AB
A. Menarini Industrie Farmaceutiche Riunite Srl
Biocare Copenhagen AS
SOFAR SpA
Mead Johnson Nutrition Company
Hebron USA Corp
Friesland Coberco Dairy Foods Holding NV
Ferring Holding SA
Chr. Hansen Holding A/S
CEBIS International

【レポートのキーワード】

小児仙痛、治験、臨床試験、治療薬

★調査レポート[小児仙痛:世界の治験レビュー(2017年下半期版)] (コード:GDHC4653CTIDB)販売に関する免責事項を必ずご確認ください。
★調査レポート[小児仙痛:世界の治験レビュー(2017年下半期版)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆